Recombinant factor VIIa (NovoSeven®) as a hemostatic agent

This publication has 27 references indexed in Scilit:

• NovoSeven® in warfarin-treated patients
  Blood Coagulation & Fibrinolysis, 2000
• Successful Epistaxis Control in a Patient with Glanzmann Thrombasthenia by Increased Bolus Injection Dose of Recombinant Factor VIIa
  Thrombosis and Haemostasis, 1999
• Treatment of Patients with Factor VIII and Factor IX Inhibitors with Special Focus on the Use of Recombinant Factor VIIa
  Thrombosis and Haemostasis, 1999
• The effect of recombinant factor VIIa (NovoSeven???) in healthy volunteers receiving acenocoumarol to an International Normalized Ratio above 2.0
  Blood Coagulation & Fibrinolysis, 1998
• Blood Coagulation in Hemophilia A and Hemophilia C
  Blood, 1998
• Clinical Use of Recombinant FVIIa (rFVIIa)
  Transfusion Science, 1998
• Recombinant factor VIIa corrects prothrombin time in cirrhotic patients: A preliminary study
  Gastroenterology, 1997
• Thrombin, Fibrin and Platelets: a Resonance Loop in which von Willebrand Factor is a Necessary Link
  Thrombosis and Haemostasis, 1997
• Fibrin in human plasma: Gel architectures governed by rate and nature of fibrinogen activation
  Thrombosis Research, 1994
• Effect of Dextran on Factor VIII (Antihemophilic Factor) and Platelet Function
  Annals of Surgery, 1979